Open AccessAnalysis of the efficacy and safety of bortezomib for treating newly diagnosed multiple myeloma through different administration methods
Author(s) -
Hongmei Zhang,
Xi-Yang Liu,
Yuzhang Liu,
Lina Liu,
Quande Lin,
Yongping Song,
Baijun Fang
Publication year - 2019
Publication title -
cancer management and research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.024
H-Index - 40
ISSN - 1179-1322
DOI - 10.2147/cmar.s218979
Subject(s) - bortezomib , medicine , multiple myeloma , adverse effect , subcutaneous injection , toxicity , surgery , gastroenterology , urology
This study aims to compare the efficacy and adverse reactions of bortezomib for treating newly diagnosed multiple myeloma (MM) through two different administration methods: intravenous (IV) injection and subcutaneous (SC) injection.